EUVIMEDEUVIMED entdecken
Crossref

BMI1 Silencing Liposomes Suppress Postradiotherapy Cancer Stemness against Radioresistant Hepatocellular Carcinoma

Meiyan Zhu iD, Haonan Fan iD, Junlin Deng iD, Ke Jiang iD, Junbin Liao iD, Xiaoyue Zhang iD, Yong Chen iD, Meng Yu iD, Zhenwei Peng iD

ACS Nano · 2023

DOI: 10.1021/acsnano.3c04636 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, 2023. Verfasst von Meiyan Zhu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: National Ten Thousand Talent Program, Sun Yat-sen University, Basic and Applied Basic Research Foundation of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsHumansLiposomesReactive Oxygen SpeciesCell Line, TumorNeoplastic Stem CellsRadiation TolerancePolycomb Repressive Complex 1Heterocyclic Compounds, 2-RingThiazoles

Stichwörter der Autor:innen

ROS-responsivecancer stem cellhepatocellular carcinomaradiotherapytumor radioresistance

Substanzen

LiposomesReactive Oxygen SpeciesPolycomb Repressive Complex 1PTC-209Heterocyclic Compounds, 2-RingThiazolesBMI1 protein, human

Autor:innen und Institutionen

  • Department of Radiation Oncology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China.
  • Institute of Precision Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China.
  • NMPA Key Laboratory for Research and Evaluation of Drug Metabolism & Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China.
  • Department of Liver Surgery, Center of Hepato-Pancreato-Biliary Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China.
  • Zhujiang Hospital, Southern Medical University, Guangzhou 510282, China.

ORCID-Profile: Meiyan Zhu, Haonan Fan, Junlin Deng, Ke Jiang, Junbin Liao, Xiaoyue Zhang, Yong Chen, Meng Yu, Zhenwei Peng

Förderung

  • National Ten Thousand Talent Program
  • Sun Yat-sen University
  • Basic and Applied Basic Research Foundation of Guangdong Province
  • Guangzhou Municipal Science and Technology Project
  • Natural Science Foundation of Guangdong Province
  • National Natural Science Foundation of China

Zitieren

APA

Zhu, M., Fan, H., Deng, J., Jiang, K., Liao, J., Zhang, X., Chen, Y., Yu, M., & Peng, Z. (2023). BMI1 Silencing Liposomes Suppress Postradiotherapy Cancer Stemness against Radioresistant Hepatocellular Carcinoma. ACS Nano. https://doi.org/10.1021/acsnano.3c04636

Vancouver

Zhu M, Fan H, Deng J, Jiang K, Liao J, Zhang X, et al. BMI1 Silencing Liposomes Suppress Postradiotherapy Cancer Stemness against Radioresistant Hepatocellular Carcinoma. ACS Nano. 2023. doi:10.1021/acsnano.3c04636

BibTeX
@article{Zhu2023,
  author = {Zhu, Meiyan and Fan, Haonan and Deng, Junlin and Jiang, Ke and Liao, Junbin and Zhang, Xiaoyue and Chen, Yong and Yu, Meng and Peng, Zhenwei},
  title = {BMI1 Silencing Liposomes Suppress Postradiotherapy Cancer Stemness against Radioresistant Hepatocellular Carcinoma},
  journal = {ACS Nano},
  year = {2023},
  doi = {10.1021/acsnano.3c04636}
}
Kostenlos starten →